Skip to main content
. 2017 Apr 10;34(8):1584–1600. doi: 10.1007/s11095-017-2153-z

Fig. 2.

Fig. 2

Structures of the physiologically-based pharmacokinetic (PBPK) model of irinotecan and its metabolites. (a) shows a module of PBPK model. The liver compartment was adapted as a permeability-limited model and divided into five compartments (23) to construct a model similar to the dispersion model. Enterohepatic circulation was considered. Permeability between the intestinal lumen and enterocytes and between enterocytes and mucosal blood was also incorporated. Portal vein blood flow was divided into mucosal blood flow (Qmucosa) and serosal blood flow (Qserosa). (b) Each module for irinotecan and the metabolites is connected shown here based on the scheme in Fig. 1.